NCT05858502 - Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

March 15, 2026

Study Completion Date

June 18, 2026

Conditions

COVID-19

Interventions

BIOLOGICAL

Blood sample collection

Blood sample collection between inclusion and 3 months max 55 ml at each visit

OTHER

Saliva sample collection

Saliva sample collection between inclusion and 3 months

OTHER

Nasopharyngeal and nasal sample collection

Nasopharyngeal and nasal sample collection between inclusion and 3 months

OTHER

Exhaled Breath Condensate (EBC)

Exhaled Breath Condensate (EBC) between inclusion and 3 months

Trial Locations (1)

RECRUITING

Institut Pasteur - ICAReB-clin, Paris